Xcout Intel
Perfuse Therapeutics
Perfuse Therapeutics, Inc. is a biopharmaceutical company pioneering treatments in clinical medicine, with operations based in San Francisco, California.
Subscribe to see Perfuse Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Perfuse Therapeutics at a glance
Perfuse Therapeutics is a therapeutics company headquartered in United States. It has raised at least $20M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round raised $9M in July 2020.
Perfuse Therapeutics funding rounds
At least $20M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9M | — | |
| Series A | $9M | — | |
| SEC Form D filing | $2M | — | |
| Seed | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Perfuse Therapeutics news
- AcquisitionBayer Completes Acquisition of Perfuse Therapeutics - VisionMonday.com
- AcquisitionBayer Completes Acquisition Of Perfuse Therapeutics In Deal Worth Up To $2.45 Billion - Pulse 2.0
- AcquisitionBayer completes acquisition of Perfuse Therapeutics - Bayer
- Acquisitionבאייר, חברת התרופות העולמית רוכשת את Perfuse האמריקנית - ביזפורטל
5 corporate events on record, with sources — see the full timeline →
Investors
Perfuse Therapeutics competitors
A few of Perfuse Therapeutics's closest competitors — see the full list of competitors and alternatives →
Telo Therapeutics, Inc. is a biotechnology company located in San Francisco, California, focused on biomedical research and therapeutic development. The company operates within the life sciences sector developing specialized medical solutions.
Rubedo Life Sciences is a clinical-stage biopharmaceutical company headquartered in Sunnyvale and Mountain View, California, developing a broad portfolio of innovative therapies.
Soteria Biotherapeutics, Inc. is a biopharmaceutical company founded in 2018 and headquartered in San Francisco, California, specializing in biopharmaceutical advancements and drug pipelines.
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Bluejay Therapeutics is a private biopharmaceutical and biotechnology research company based in San Francisco, California. The company focuses on developing innovative treatments and therapies for viral and liver diseases.
Get Perfuse Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Perfuse Therapeutics in Xcout Intel
- 4 funding rounds with the investors in each, and who they co-invest with
- 5 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access